Sunday, June 28, 2026

Alabama Medicaid has paused the implementation of its new prior referral requirement for Applied Behavior Analysis (ABA) therapy for autism. The rule, which was set to take effect July 1, 2026, required pediatricians to complete specific referrals. The pause means providers should continue submitting ABA therapy claims under the existing prior authorization process without the new referral form. This is a direct operational reprieve for pediatric and behavioral health practices serving Medicaid patients in Alabama. Update internal workflows to remove the planned July 1 procedural change. Continue to monitor the Alabama Medicaid portal for official guidance on if and when the new requirement will be reinstated.

MassHealth, Massachusetts's Medicaid program, will terminate coverage for GLP-1 weight-loss drugs effective next week. The policy reversal comes amid rising program costs. Clinics serving MassHealth patients must immediately inform patients currently on these medications and prepare for coverage terminations. This change does not affect GLP-1 drugs approved for diabetes management. Prior authorizations for weight-loss indications will be denied after the cutoff. Billing teams should verify the exact discontinuation date through MassHealth bulletins and flag affected patients for potential cash-pay discussions or therapeutic alternatives.

CMS has launched its temporary GLP-1 Bridge program for weight-loss drugs like Wegovy and Zepbound. This pilot offers Medicare beneficiaries access at a $50 monthly co-pay, a significant discount from typical out-of-pocket costs. The bridge program is designed to cover beneficiaries until broader coverage decisions are finalized. Practices should prepare for patient inquiries about coverage and prescribing requirements. Verify patient eligibility through the standard Medicare Part D channels and ensure documentation supports medical necessity for obesity treatment, as standard coverage criteria still apply. Monitor CMS communications for the program's official start date and operational details.

Alabama Medicaid will not enforce its July 1, 2026, deadline requiring pediatricians to complete specific training before referring children for autism spectrum disorder evaluations. The agency announced a pause following significant pushback from provider groups who argued the rule would delay access to Applied Behavioral Analysis therapy. The requirement, part of Alabama's broader Medicaid reforms, mandated pediatricians obtain certification through a designated course. Clinics with pediatric practices in Alabama should suspend implementation of this workflow until Medicaid issues new guidance. Monitor the state Medicaid portal for the revised compliance date.

Private equity firm Carlyle Group is considering an initial public offering for a healthcare revenue cycle management provider it recently acquired. This move signals continued investor confidence in the RCM technology and outsourcing sector, particularly as AI tools for coding, denials management, and prior authorization gain traction. The potential IPO reflects a market valuation based on growth through automation and data analytics. For independent practices, this trend underscores the accelerating investment in backend healthcare operations, which may lead to more AI-powered vendor solutions and potential industry consolidation among billing service providers.